These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 2548431)

  • 21. Hepatocellular carcinoma in childhood.
    McDougal RA
    Arch Pathol Lab Med; 1979 Aug; 103(9):489. PubMed ID: 223521
    [No Abstract]   [Full Text] [Related]  

  • 22. Clinicopathological aspects of primary hepatocellular carcinoma occurring in patients with liver cirrhosis.
    Iwamura K
    Tokai J Exp Clin Med; 1982 Sep; 7(5):589-605. PubMed ID: 6190271
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The role of transplantation in small hepatocellular carcinoma complicating cirrhosis of the liver.
    Romani F; Belli LS; Rondinara GF; DeCarlis L; Rimoldi P; Riolo F; Bellati G; Ideo G; Belli L
    J Am Coll Surg; 1994 Apr; 178(4):379-84. PubMed ID: 8149037
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Two cases of non-alcoholic steatohepatitis with development of hepatocellular carcinoma without cirrhosis.
    Ichikawa T; Yanagi K; Motoyoshi Y; Hamasaki K; Nakao K; Toriyama K; Eguchi K
    J Gastroenterol Hepatol; 2006 Dec; 21(12):1865-6. PubMed ID: 17074033
    [No Abstract]   [Full Text] [Related]  

  • 25. Hepatocellular carcinoma and cirrhosis in Thailand: etiologic considerations of underlying cirrhosis.
    Suwangool P
    J Med Assoc Thai; 1980 May; 63(5):245-9. PubMed ID: 6248611
    [No Abstract]   [Full Text] [Related]  

  • 26. [Incidence of hepatocellular carcinomas in liver cirrhosis].
    Lehmann FG; Martini GA
    Verh Dtsch Ges Inn Med; 1975; 81():1384-7. PubMed ID: 179239
    [No Abstract]   [Full Text] [Related]  

  • 27. [Indications and results of liver transplantation in the treatment of hepatocellular carcinoma in cirrhosis].
    Adam R; Castaing D; Azoulay D; Majno P; Samuel D; Bismuth H
    Ann Chir; 1998; 52(6):547-57. PubMed ID: 9752505
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Relationship between hepatocellular carcinoma, liver cirrhosis and hepatitis B: a pathological study].
    Zhonghua Yi Xue Za Zhi; 1982 May; 62(5):257-61. PubMed ID: 6290005
    [No Abstract]   [Full Text] [Related]  

  • 29. [Continuing education. Treatment of hepatocellular carcinoma in cirrhosis. Introduction].
    Castaing D
    Ann Chir; 1998; 52(6):509-10. PubMed ID: 9752499
    [No Abstract]   [Full Text] [Related]  

  • 30. [A case of cancer of the liver in an 8-year-old child with post-inflammatory liver cirrhosis].
    Cielecka-Kuszyk J; Husein N; Nałecz A; Kluge P; Rejman E
    Pediatr Pol; 1987 Apr; 62(4):245-8. PubMed ID: 2823209
    [No Abstract]   [Full Text] [Related]  

  • 31. Clinicomorphological manifestations of primary liver carcinoma (PLC) in liver cirrhosis.
    Ferlan-Marolt V; Markovic S
    Cancer Detect Prev; 1986; 9(5-6):491-3. PubMed ID: 3022928
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact of tumor factors on the prognosis of patients with advanced cirrhosis (Child-Pugh class C) and hepatocellular carcinoma.
    Toyoda H; Kumada T; Kiriyama S; Sone Y; Tanikawa M; Hisanaga Y; Hayashi K; Honda T; Kuzuya T; Nonogaki K; Shimizu J
    J Gastroenterol Hepatol; 2005 Jun; 20(6):963-5. PubMed ID: 15946154
    [No Abstract]   [Full Text] [Related]  

  • 33. Recovery from liver failure after hepatectomy for hepatocellular carcinoma in cirrhosis: meaning of the model for end-stage liver disease.
    Cucchetti A; Ercolani G; Cescon M; Ravaioli M; Zanello M; Del Gaudio M; Lauro A; Vivarelli M; Grazi GL; Pinna AD
    J Am Coll Surg; 2006 Nov; 203(5):670-6. PubMed ID: 17084328
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Risk factors for hepatocellular carcinoma in HCV-cirrhosis: what we know and what is missing.
    Fattovich G; Llovet JM
    J Hepatol; 2006 Jun; 44(6):1013-6. PubMed ID: 16678654
    [No Abstract]   [Full Text] [Related]  

  • 35. [Current approach to hepatic carcinogenesis. From cirrhosis to hepatocellular carcinoma].
    Le Bail B; Bioulac-Sage P; Tran van Nhieu J; Zafrani ES
    Ann Pathol; 1995; 15(5):332-47. PubMed ID: 8540919
    [No Abstract]   [Full Text] [Related]  

  • 36. Does increased fatty acid oxidation enhance development of liver cirrhosis and progression to hepatocellular carcinoma in patients with glycogen storage disease type-III?
    Herrema H; Smit GP; Reijngoud DJ; Kuipers F
    J Hepatol; 2007 Aug; 47(2):298-300; author reply 300-1. PubMed ID: 17570555
    [No Abstract]   [Full Text] [Related]  

  • 37. Risk factors for hepatocellular carcinoma in patients with chronic liver diseases.
    Ciernik IF
    N Engl J Med; 1993 Dec; 329(25):1897; author reply 1897-8. PubMed ID: 8247051
    [No Abstract]   [Full Text] [Related]  

  • 38. [Liver and hereditary alpha 1-antitrypsin deficiency].
    Feldmann G
    Gastroenterol Clin Biol; 1993; 17(2):83-93. PubMed ID: 8388836
    [No Abstract]   [Full Text] [Related]  

  • 39. Abdominal drainage after liver resection for hepatocellular carcinoma in cirrhotic patients: a randomized controlled study.
    Fuster J; Llovet JM; Garcia-Valdecasas JC; Grande L; Fondevila C; Vilana R; Palacin J; Tabet J; Ferrer J; Bruix J; Visa J
    Hepatogastroenterology; 2004; 51(56):536-40. PubMed ID: 15086197
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Primary cancer of the liver superimposed upon cirrhosis].
    Caroli J; Marcus N; Grynblat A; Chevrel B
    Rev Med Chir Mal Foie; 1970; 45(6):291-8. PubMed ID: 4322956
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.